Anne Horgan
InvestorPartner at Cambridge Innovation Capital
Paris, France
Writes $600K – $6M checks · typically $3.3M
About
Anne Horgan blends McKinsey strategy consulting with synthetic organic and medicinal chemistry (PhD Cambridge; Max Planck postdoc; GSK), formalizing university-commercial links via a Clare Hall fellowship and BioIndustry Association board
Invests in
AI & Machine LearningBiotechDeep TechHardwareHealthtechSemiconductors
Experience
- Cambridge Innovation CapitalPartnercurrent2021 — present
- Advent France BiotechnologyPartner2017 — 2021Paris
- Sofinnova PartnersSenior Associate - Life Sciences2016 — 2017Greater Paris Metropolitan Region
- Sofinnova PartnersAssociate - Life Sciences2013 — 2015Greater Paris Metropolitan Region
- Cancer Research TechnologyBusiness Development Executive2012 — 2013
- Cancer Research TechnologyBusiness Development Manager2009 — 2012
- Cancer Research TechnologyProject Development Manager2007 — 2009
- Cambridge Biotechnology Ltd, a part of the Biovitrum GroupSenior Scientist, Medicinal Chemistry2003 — 2007
- Yale UniversityPostdoctoral Fellow2001 — 2002
Education
- Yale UniversityPostdoc, Chemistry2001 — 2002
- University of BristolPh.D., Synthetic Organic Chemistry1997 — 2001
- INSA Rouen NormandieDiplôme d'ingénieur, Chemistry (Chimie Fine et Ingénierie)1992 — 1997
Skills & more
Chemistry9Medicinal Chemistry5Lifesciences15Drug Discovery14R&D8Technology Transfer11Intellectual Property5Organic Chemistry3Biotechnology5Patents2Commercialization3Biochemistry3
+4 more
Protein ChemistryDrug DevelopmentBiopharmaceuticalsPharmaceutical IndustryLanguages English · French
From Anne's professional profile.
Same school
Also attended Yale University491
Ann Miura-KoCo-founding Partner at FloodgateDavid SzeAdvisory Partner at GreylockMichael SeibelPartner Emeritus at Y CombinatorZheela QaiserInvestor at Index VenturesKarthik ArdhanareeswaranInvestor at GV (Google Ventures)TinaInvestments & Portfolio Services Team Member at Clear Ventures
+ 485 more
Also attended University of Bristol129
Chris BischoffInvestment Team at General CatalystSaran DaviesInvestor at Moonfire VenturesThomas RubensInvestor at DN CapitalIgnacio García LeónEntrepreneur in Residence at FJ LabsAnnabel StoddartOffice Manager and Executive Assistant at Medical Excellence CapitalMichael PatersonCo-founder & former CTO at Asymmetric Capital Partners
+ 123 more
Also attended INSA Rouen Normandie1
Shared employers
Also worked at Sofinnova Partners44
Laetitia SchwabPrincipal at SR One Capital ManagementAntoine Papiernik PapiernikChairman and Managing Partner at Sofinnova PartnersGraziano SeghezziManaging Partner at Sofinnova PartnersMichael KrelPartner at Sofinnova PartnersHenrijette RichterManaging Partner at Sofinnova PartnersZhizhong YaoPartner at Sofinnova Partners
+ 38 more
Also worked at Cancer Research Technology1
Colleagues at Cambridge Innovation Capital
Adam Glinsman
Investor at Cambridge Innovation Capital
Andrew Williamson
Managing Partner at Cambridge Innovation Capital
Andy Neely
Vice Chair at Cambridge Innovation Capital
Andy Richards
Investor at Cambridge Innovation Capital
Christopher Tapper
Senior Associate at Cambridge Innovation Capital
Damian Crowther
Entrepreneur in Residence at Cambridge Innovation Capital
Dipesh Patel
Operating Partner at Cambridge Innovation Capital
Edward Inns
Principal at Cambridge Innovation Capital
Network5
Andrew Williamson
Managing Partner at Cambridge Innovation Capital
Christopher Tapper
Senior Associate at Cambridge Innovation Capital
Edward Inns
Principal at Cambridge Innovation Capital
Ian Lane
Partner at Cambridge Innovation Capital
Michael Anstey
Partner at Cambridge Innovation Capital
Investors connected to Anne in public investor directories — a warm-intro map.





.jpg)















%20(1).png)










